Authors
Rina Mauricio, Anita Deswal, Kathryn J Ruddy, Nausheen Akhter, Ming Hui Chen, Imo A Ebong, Niti R Aggarwal, Colleen M Harrington, Carlos H Barcenas, Melissa Pulfer Mitchell, Leslie Cho, Anju Nohria
Published in
JAMA cardiology. Jul 29, 2026. Epub Jul 29, 2026.
Abstract
Breast cancer is the most common cancer diagnosed in women. Therapies for breast cancer are evolving rapidly, and several are associated with cardiovascular adverse effects, can exacerbate cardiovascular risk factors, or can increase the risk of cardiovascular disease.
Advances in screening and treatment have led to earlier diagnosis and improved disease-free survival. For long-term survivors of breast cancer, cardiovascular adverse effects can pose a greater threat to overall long-term health than the cancer itself. Additionally, the increasing incidence of breast cancer in younger, premenopausal women has created a distinct demographic with unique medical needs.
Cardiology practitioners need to remain updated on rapidly evolving breast cancer therapies to care for this growing, unique patient population. The field of cardio-oncology has evolved to address the cardiovascular needs of patients and survivors.
PMID:
42525430
Bibliographic data and abstract were imported from PubMed on 29 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 10
- Comments 0